Law office of Brodsky & Smith, LLC announces that it is investigating potential claims against the Board of Directors of Mediware Information Systems, Inc. (“Mediware” or the “Company”) (Nasdaq: MEDW) relating to the proposed acquisition by Thoma Bravo (“Thoma Bravo”).
Under the terms of the transaction, Mediware shareholders will receive only $22.00 in cash for each share of Mediware stock they own. The investigation concerns possible breaches of fiduciary duty and other violations of state law by the Board of Directors of Mediware for not acting in the Company’s shareholders' best interests in connection with the sale process to Thoma Bravo. Specifically, the investigation seeks to determine if conflicts of interest played a role in the Board’s decision. The Company’s directors and executives own approximately 37.9% of the common shares. In addition, it has been reported, that the Chairman of the Board owns stock which would be worth an estimated $54.3 million.
If you own shares of Mediware stock and wish to discuss the legal ramifications of the proposed transaction, or have any questions, you may e-mail or call the law office of Brodsky & Smith, LLC who will, without obligation or cost to you, attempt to answer your questions. You may contact Jason L. Brodsky, Esquire or Evan J. Smith, Esquire at Brodsky & Smith, LLC, Two Bala Plaza, Suite 602, Bala Cynwyd, PA 19004, by e-mail at
, or by calling toll free 877-LEGAL-90.